Fernández-Díaz, Eva; Pérez-Vicente, José-Antonio; Villaverde-González, Ramón; Berenguer-Ruiz, Leticia; Candeliere-Merlicco, Antonio; Martínez-Navarro, María-Luisa; Gracia-Gil, Julia; Romero-Sánchez, Carlos-M; Alfaro-Saez, Arantxa; Díaz, Inmaculada; Giménez-Martínez, Juana; Méndez-Miralles, María-Ángeles; Millán-Pascual, Jorge; Jiménez-Pancho, Javier; Mola, Santiago; Sempere, Ángel-P
(Wiley, 2021-02)
OBJECTIVE: Pivotal trial have shown that patients with multiple sclerosis (MS) receiving ocrelizumab had better outcomes. However, data on ocrelizumab in clinical practice are limited. The aim of this study was to evaluate ...